- Lymphocyte depleting and modulating therapies for chronic lung allograft dysfunction2023 | Second Faculty of Medicine
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis2022 | Faculty of Medicine in Pilsen
- Processing the hematopoietic progenitor grafts and their use in clinical practice2002 | Second Faculty of Medicine
- Vaccination of the patients with autoimmune inflammatory disease on treatment with new biologics and JAK inhibitors2019 | First Faculty of Medicine
- Phosphorylation of histone H2AX in peripheral blood mononuclear cells after thoracic irradiation of rats2011 | Faculty of Medicine in Hradec Králové
- The Effect of Induction Therapy on Established CMV Specific T Cell Immunity in Living Donor Kidney Transplantation2018 | Central Library of Charles University